Floatz logo

Fenretinide

Cutaneous/Peripheral T-Cell Lymphoma

SciTech Development, Inc.Small moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Cutaneous/Peripheral T-Cell Lymphoma cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Fenretinide is also rated in:

primary peritoneal carcinomaDormant
B
Indicative ·
58 / 100
View asset →
cancerDormant
B
Indicative ·
56 / 100
View asset →
cognitive disorderDormant
B
Indicative ·
56 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →